Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...

Switzerland’s Galderma today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...

Ad hoc announcement pursuant to Art. 53 LR This approval from the European Commission is based on robust results from the phase III OLYMPIA and ...

Rare Cannabinoid Company, a leader in hemp-derived wellness products, is celebrating February Sleep Awareness Month with an exclusive Buy One, Get One 50% Off sale on all CBN ...

Valmet announced on December 18, 2024, that the Board of Directors of Valmet has decided to use the authorization granted by the Annual General Meeting held on March 21, 2024, to repurchase the ...

GSK has had another setback in its oncology business, after the FDA asked it to restrict use of its PARP inhibitor Zejula in ovarian, fallopian tube, or primary peritoneal cancer to patients with ...

References UK Health Security Agency. Weekly national Influenza and COVID-19 surveillance report. Week 47 report (up to week 46 data). Available at: https://assets.publishing.service.gov.uk ...

The state’s life sciences industry honored its own last Thursday night at BioNJ’s annual Dinner Meeting & Innovation Celebration. Held at the Hilton East Brunswick, the gala represented a who’s who of ...